Hunter Gillies
Chief Tech/Sci/R&D Officer at AEROVATE THERAPEUTICS, INC.
Net worth: 96 132 $ as of 2024-03-30
Profile
Hunter Gillies is currently the Chief Medical Officer at Aerovate Therapeutics, Inc. He previously worked as the Senior Director-Clinical Research at Gilead Sciences, Inc. from 2010 to 2015.
He also worked as the Chief Medical Officer at Bellerophon Therapeutics, Inc. Dr. Gillies received his undergraduate and graduate degrees from the University of Cape Town.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-16 | 3,251 ( 0.01% ) | 96 132 $ | 2024-03-30 |
Hunter Gillies active positions
| Companies | Position | Start |
|---|---|---|
| AEROVATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-04-30 |
Former positions of Hunter Gillies
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2015-11-30 |
| BELLEROPHON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Hunter Gillies
| University of Cape Town | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| AEROVATE THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Hunter Gillies
